Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 5/20 | 0.38 |
| ▸ | NPY1R | P25929 | 3/20 | 0.38 |
| ▸ | NPY2R | P49146 | 2/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.38 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
| ▸ | KISS1R | Q969F8 | 10/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | FCER2 | P06734 | 1/20 | 0.37 |
| ▸ | GRB2 | P62993 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30656926 | 0.92 | MMP2 (0.40) | KISS1RMMP1FCER2 | |
| SCHEMBL30495730 | 0.91 | BACE1 (0.41) | OPRD1 | |
| SCHEMBL30728878 | 0.87 | MME (0.43) | NPY4RNPY1RNPY2R | |
| SCHEMBL3970381 | 0.86 | MMP7 (0.38) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL1404310 | 0.86 | MMP7 (0.38) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28758381 | 0.86 | MMP7 (0.38) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL2181812 | 0.86 | BACE1 (0.34) | KISS1RMMP1 | |
| SCHEMBL29886675 | 0.85 | BACE1 (0.40) | NPY4RNPY1RNPY2R | |
| SCHEMBL29442611 | 0.85 | MME (0.41) | NPY4RNPY1RNPY2ROPRD1 | |
| SCHEMBL30873804 | 0.84 | FCER2 (0.41) | NPY4RNPY1RNPY2RNPY5RREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | PARABILIS MEDICINES, INC. | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | ESRRB, ESR1, ESRRA | NPY4R 59/4885NPY1R 18/4885NPY2R 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.